Product Wiki · Recalls · Health Canada — Medical Devices

ENDOBON XENOGRAFTANULE GRS (2016-01-25) — recall 54853

Health Canada — Medical Devices · Canada · 2016-02-08 · Type II

Compiled from an official source — the facts on this page are reproduced from the issuing authority’s own published notice, which is linked above. No AI-generated text appears on this page. How we use AI →
Agency
Health Canada — Medical Devices
Recall identifier
54853
Date of alert
2016-02-08
Country / jurisdiction
Canada
Risk level
Type II
Risk type
recall
Product category
Medical devices
Product type
Medical devices
Notice status
Archived by the issuing authority — kept for reference
Reported risk: The cytotoxicity study of Endobon Xenograft Granules revealed severe (grade 4) toxicity after 36 months real-time ageing. This finding was also reported after accelerated ageing equivalent to 36 months real-time.
Primary source: https://recalls-rappels.canada.ca/en/alert-recall/endobon-xenograftanule-grs-201

Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.

Related

ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.